📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Core Modifications of GSK3335103 toward Orally Bioavailable avß6 Inhibitors with Improved Synthetic Tractability. (2024)

First Author: Hryczanek HF

Attributed to: Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.4c02051

PubMed Identifier: 39417301

Publication URI: http://europepmc.org/abstract/MED/39417301

Type: Journal Article/Review

Volume: 67

Parent Publication: Journal of medicinal chemistry

Issue: 21

ISSN: 0022-2623